Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imaging-Reference-Cited by-同舟云学术

Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imaging

Published:2014-05 Issue: Volume:182 Page:83-89
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Theek Benjamin,Gremse Felix,Kunjachan Sijumon,Fokong Stanley,Pola Robert,Pechar Michal,Deckers Roel,Storm Gert,Ehling Josef,Kiessling Fabian,Lammers Twan

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference49 articles.

1. The emerging nanomedicine landscape;Wagner;Nat. Biotechnol.,2006

2. Nanocarriers as an emerging platform for cancer therapy;Peer;Nat. Nanotechnol.,2007

3. Tumour-targeted nanomedicines: principles and practice;Lammers;Br. J. Cancer,2008

4. Nanomedicine;Kim;N. Engl. J. Med.,2010

5. Nanomedicine(s) under the microscope;Duncan;Mol. Pharm.,2011

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyester nanoparticles delivering chemotherapeutics: Learning from the past and looking to the future to enhance their clinical impact in tumor therapy;WIREs Nanomedicine and Nanobiotechnology;2024-09

2. Nanomedicine Tumor Targeting;Advanced Materials;2024-04-12

3. Histopathological biomarkers for predicting the tumour accumulation of nanomedicines;Nature Biomedical Engineering;2024-04-08

4. Using imaging modalities to predict nanoparticle distribution and treatment efficacy in solid tumors: The growing role of ultrasound;WIREs Nanomedicine and Nanobiotechnology;2024-03

5. Lipid nanoparticles loaded with anticancer bioactives: state of the art;Cancer Therapy;2024